The global botulinum toxin (BNT) market is expected to reach
a value of USD 7.3 billion by 2025. The constant introduction of innovative
products for enhancement of aesthetic appeal supporting minimally invasive
aesthetic treatments is the prime factor driving the growth of the market.
In addition, rapid growth of the
sector is attributed to the rising demand for minimally invasive or
non-invasive procedures. These procedures provide advantages such as small
incision, shorter hospital stay and rapid wound healing, and hence lead to larger
acceptance and demand. In addition, availability of wide variety of minimally
invasive or non-invasive treatment options is pushing the global botulinum
toxin market towards growth.
Also, the successful completion of
research projects is expected to expand the applications of presently approved
products. Companies are trying to widen the application of botulinum toxin in
therapeutic area through various research activities. For instance, Botox by
Allergan received the U.S. FDA approval for the treatment of strabismus
(crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore,
in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical
dystonia, upper limb spasticity, chronic migraine and urinary incontinence in
2009, 2010 and 2011 respectively. Hence, these factors all together will aid in
boosting the growth of BNT sales during the forecast period.
Browse full research report on Botulinum Toxin Market: https://www.grandviewresearch.com/industry-analysis/botulinum-toxin-market
Further Key Findings from the Study Suggest:
- The rapid adoption of minimally invasive treatment is
augmenting the growth of neurotoxins market.
- The botulinum toxin type A segment accounted for the largest
share in 2015 and is also anticipated to be the fastest growing segment
during the forecast period
- In 2015, North America dominated the global space with the
largest revenue share owing to high demand for minimally invasive or
non-invasive aesthetic treatments
- Asia Pacific is expected to emerge as the fastest growing
region during the forecast period, mainly due to growing social awareness
regarding anti-wrinkle procedures in India, China, and Japan
- Major players competing in this market include but are not
limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA,
Medytox,Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products.
Co.Ltd. and Revance Therapeutics, Inc.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/botulinum-toxin-market/request/rs1
Grand View Research has segmented the botulinum toxin market by
type, end use, and region:
Product Type Outlook (Revenue, USD Million; 2013 - 2025)
- Botulinum
Toxin Type A
- Botulinum
Toxin Type B
End Use Outlook (Revenue, USD Million; 2013 - 2025)
- Therapeutic
- Aesthetic
Regional Outlook (Revenue, USD Million; 2013 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Mexico
- Brazil
- MEA
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment